US FDA authorises Eli Lilly’s COVID-19 antibody drug
The FDA authorised bebtelovimab for emergency use in patients with mild-to-moderate COVID-19 who are at high risk of progression…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
China approves use of Pfizer’s COVID drug Paxlovid
It is not immediately clear if China is already in talks with Pfizer to procure the pill
Zydus gets 180 days’ shared exclusivity for Roflumilast tablets
Zydus’ Roflumilast tablets are indicated as a treatment to reduce the risk of Chronic Obstructive Pulmonary Disease (COPD)…
WHO grants prequalification of Roche’s Actemra/RoActemra for patients with severe COVID
Since the beginning of the pandemic, more than one million patients with severe COVID-19 have been treated with Actemra/RoActemra,…
LANXESS appoints Neelanjan Banerjee as Global Head of its Lubricant Additives Business
Banerjee is taking over from Martin Saewe who moves on to become the Head of Group Initiative E-Mobility and Circular Economy
Novartis India extends access to its medicines in India with Dr Reddy’s Laboratories
This brings together the manufacturing and development synergies of Novartis with the sales and distribution strengths of Dr…
EdiGene and Neukio enter collaboration to develop next-generation immune cell therapies
The collaboration will leverage EdiGene’s expertise in high-throughput genome editing screening and Neukio’s strength in the…
Decision on third dose of COVID-19 vaccine for all adults will be based on scientific need:…
Responding to a question at a weekly press conference, Dr V K Paul, Member (health), NITI Aayog, said all decisions on precaution…
DTAB recommends granting licence to manufacture, stock new drugs, jabs under clinical trial
Various industry experts and subject experts are of opinion that if the government approves recommendation of DTAB and DCGI, it…
India’s first homegrown mRNA COVID-19 vaccine currently under final clinical trial stages:…
The vaccine is being developed by Pune-based Gennova Biopharmaceuticals, informed Dr VK Paul, Member (health), NITI Aayog